ZLAB Financial Statements & Analysis
Complete financial statements for ZLAB including income statement, balance sheet, and cash flow statement. Analyze ZLAB's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
15.3% ↑
Net Income
31.7% ↑
Gross Margin
-7.1% ↓
Operating Margin
31.3% ↑
Balance Sheet
Current Ratio
-30.2% ↓
Debt to Equity
71.7% ↓
Asset Turnover
16.6% ↑
Cash Flow
Operating Cash Flow
29.8% ↑
Net Cash Flow
195.6% ↑
Free Cash Flow
42.5% ↑
Cash Flow to Debt
52.0% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 398.99M | 460.16M | 15.3% | |
| Gross Profit | 251.13M | 269.07M | 7.1% | |
| Operating Income | -282.12M | -223.57M | 20.8% | |
| Net Income | -257.10M | -175.54M | 31.7% | |
| EPS | -2.60 | -1.60 | 38.5% | |
| EBITDA | -234.57M | -158.25M | 32.5% | |
| Gross Margin | 62.94% | 58.47% | 7.1% | |
| Operating Margin | -70.71% | -48.59% | 31.3% | |
| Net Income Margin | -64.44% | -38.15% | 40.8% | |
| R&D Expenses | 234.50M | 220.90M | 5.8% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 460.16M | 398.99M | 266.72M | — | — |
| Gross Profit | 269.07M | 251.13M | 170.90M | — | — |
| Operating Income | -223.57M | -282.12M | -366.57M | — | — |
| Net Income | -175.54M | -257.10M | -334.62M | — | — |
| EPS | -1.60 | -2.60 | -34.60 | — | — |
| EBITDA | -158.25M | -234.57M | -365.11M | — | — |
| Gross Margin | 58.47% | 62.94% | 64.08% | — | — |
| Operating Margin | -48.59% | -70.71% | -137.44% | — | — |
| Net Income Margin | -38.15% | -64.44% | -125.46% | — | — |
| R&D Expenses | 220.90M | 234.50M | 265.87M | — | — |
Financial Metrics
Want to dive deeper into ZLAB's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics